965 related articles for article (PubMed ID: 15993820)
1. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
2. Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan.
Bulka A; Wiesenfeld-Hallin Z; Xu XJ
Brain Res; 2002 Jun; 942(1-2):95-100. PubMed ID: 12031857
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
[TBL] [Abstract][Full Text] [Related]
4. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
5. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
Lutfy K; Doan P; Weber E
Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
[TBL] [Abstract][Full Text] [Related]
6. Opioid antinociception, tolerance and dependence: interactions with the N-methyl-D-aspartate system in mice.
Dykstra LA; Fischer BD; Balter RE; Henry FE; Schmidt KT; Miller LL
Behav Pharmacol; 2011 Sep; 22(5-6):540-7. PubMed ID: 21712708
[TBL] [Abstract][Full Text] [Related]
7. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat.
Redwine KE; Trujillo KA
Pharmacol Biochem Behav; 2003 Sep; 76(2):361-72. PubMed ID: 14592689
[TBL] [Abstract][Full Text] [Related]
8. Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959).
Fischer BD; Miller LL; Henry FE; Picker MJ; Dykstra LA
Psychopharmacology (Berl); 2008 Jun; 198(2):271-8. PubMed ID: 18392754
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the polyamine site of NMDA receptors produces antinociception and enhances the effect of morphine, in mice.
Bernardi M; Bertolini A; Szczawinska K; Genedani S
Eur J Pharmacol; 1996 Feb; 298(1):51-5. PubMed ID: 8867919
[TBL] [Abstract][Full Text] [Related]
10. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
[TBL] [Abstract][Full Text] [Related]
11. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
Baker AK; Hoffmann VL; Meert TF
Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
[TBL] [Abstract][Full Text] [Related]
12. Modulation of morphine analgesia by site-specific N-methyl-D-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time.
Nemmani KVS; Grisel JE; Stowe JR; Smith-Carliss R; Mogil JS
Pain; 2004 Jun; 109(3):274-283. PubMed ID: 15157688
[TBL] [Abstract][Full Text] [Related]
13. Involvement of glutamatergic receptors in the nucleus cuneiformis in modulating morphine-induced antinociception in rats.
Haghparast A; Gheitasi IP; Lashgari R
Eur J Pain; 2007 Nov; 11(8):855-62. PubMed ID: 17291798
[TBL] [Abstract][Full Text] [Related]
14. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
Craft RM; Lee DA
Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
[TBL] [Abstract][Full Text] [Related]
15. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects.
Fischer BD; Ward SJ; Henry FE; Dykstra LA
Neuropharmacology; 2010 Feb; 58(2):544-50. PubMed ID: 19699755
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
Sakurada T; Watanabe C; Okuda K; Sugiyama A; Moriyama T; Sakurada C; Tan-No K; Sakurada S
Brain Res Mol Brain Res; 2002 Jan; 98(1-2):111-8. PubMed ID: 11834301
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the N-methyl-d-aspartate receptor unmasks the antinociception of endogenous opioids in the periphery.
Zhang GH; Min SS; Seol GH; Lee KS; Han H; In Kim Y; Han HC
Pain; 2009 Jun; 143(3):233-237. PubMed ID: 19361925
[TBL] [Abstract][Full Text] [Related]
19. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
20. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor.
Allen RM; Granger AL; Dykstra LA
J Pharmacol Exp Ther; 2003 Nov; 307(2):785-92. PubMed ID: 12975489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
